{
    "slug":  "alzheimers-breakthrough-treatment-2025",
    "category":  "Research",
    "title":  "Breakthrough Alzheimer\u0027s Treatment Shows 70% Cognitive Improvement in Trials",
    "introText":  "A revolutionary Alzheimer\u0027s treatment has shown unprecedented results in Phase 3 clinical trials, with patients demonstrating 70% improvement in cognitive function. The FDA is fast-tracking approval, offering hope to millions of families.",
    "readingTime":  "8 Min Read",
    "author":  {
                   "image":  "/images/authors/author-5.webp",
                   "name":  "Aisha Patel",
                   "role":  "Health \u0026 Science Correspondent"
               },
    "lastUpdated":  "December 17, 2025",
    "content":  [
                    {
                        "type":  "image",
                        "content":  "Alzheimer\u0027s treatment breakthrough",
                        "imageUrl":  "/images/news/healthcare-medical.webp",
                        "imageAlt":  "Medical research"
                    },
                    {
                        "type":  "heading",
                        "content":  "Trial Results",
                        "level":  2
                    },
                    {
                        "type":  "paragraph",
                        "content":  "Phase 3 trials involving 3,000 patients showed 70% improvement in cognitive assessments and 60% reduction in disease progression. Some early-stage patients returned to near-normal function."
                    },
                    {
                        "type":  "heading",
                        "content":  "Mechanism",
                        "level":  2
                    },
                    {
                        "type":  "paragraph",
                        "content":  "The treatment combines amyloid-clearing antibodies with a novel approach targeting tau proteins. The dual mechanism addresses both hallmarks of Alzheimer\u0027s disease."
                    },
                    {
                        "type":  "heading",
                        "content":  "Timeline",
                        "level":  2
                    },
                    {
                        "type":  "paragraph",
                        "content":  "The FDA has granted breakthrough therapy designation, expediting review. Approval could come by mid-2026. If approved, 6 million Americans with Alzheimer\u0027s could benefit."
                    }
                ],
    "bookmarked":  false
}
